drugset / Trial / NCT01561521
An Evaluation of the Onset and Duration of Action of AKF-1 Ophthalmic Solution in Treating Acute Allergic Conjunctivitis
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the onset and duration of action of two concentrations of AKF-1 Ophthalmic Solution compared to vehicle in the conjunctival allergen challenge (CAC) model of acute allergic conjunctivitis.
Timeline
- Start
- 2012-03
- Primary completion
- 2012-04
- Completion
- 2012-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | AKF-1 | Unknown | 0.025 % | Other |
| Comparator | AKF-1 | Unknown | 0.035 % | Other |